We are live on
!
Find out more
CTC
Central Trust Company Portfolio holdings
AUM
$5.08B
1-Year Est. Return
25.65%
This Fund
S&P 500
This Quarter
Est. Return
-0.37%
1 Year Est. Return
+25.65%
3 Year Est. Return
+74.65%
5 Year Est. Return
+97.11%
10 Year Est. Return
+319.6%
AUM
$2.81B
AUM Growth
+$48.9M
(+1.8%)
Cap. Flow
+$76M
Cap. Flow
% of AUM
2.71%
Top 10 Holdings %
Top 10 Hldgs %
27.62%
Holding
1,320
New
131
Increased
322
Reduced
330
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US TIPS ETF
SCHP
|
+$13.8M |
| 2 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$12.1M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$11.1M |
| 4 |
Sprott Physical Gold
PHYS
|
+$6.98M |
| 5 |
Sprott Physical Silver Trust
PSLV
|
+$6.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Great Southern Bancorp
GSBC
|
+$6.74M |
| 2 |
Alibaba
BABA
|
+$4.94M |
| 3 |
PepsiCo
PEP
|
+$3.51M |
| 4 |
iShares Gold Trust
IAU
|
+$3.45M |
| 5 |
Apple
AAPL
|
+$3.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.45% |
| 2 | Healthcare | 10.07% |
| 3 | Financials | 8.14% |
| 4 | Consumer Discretionary | 7.96% |
| 5 | Industrials | 7.6% |
Similar funds
JIM
LFG
VT
LIM
NC
CS
EIC
AC
Central Trust Company's Q3 2021 Portfolio in Review
As of Q3 2021, Central Trust Company held 1,320 positions worth $2.81B, up 1.8% from $2.76B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Central Trust Company's Q3 2021 filing shows 131 new, 322 increased, 330 reduced and 64 closed positions. Its largest new stake was Schwab Short-Term US Treasury ETF: 106,000 shares worth $2.71M. The largest sale was Great Southern Bancorp, an estimated $6.74M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Central Trust Company's largest Q3 2021 buy was Schwab Short-Term US Treasury ETF: 106,000 shares worth $2.71M.
- Central Trust Company added most to Schwab US TIPS ETF in Q3 2021, an estimated $13.8M increase.
- Central Trust Company's biggest Q3 2021 reduction was Great Southern Bancorp, cutting an estimated $6.74M.
- Central Trust Company fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $949K.
- Central Trust Company's ten largest holdings make up 28% of its $2.81B portfolio in Q3 2021.
- Central Trust Company opened 131 new positions and closed 64 in Q3 2021.
- Central Trust Company's portfolio value rose 1.8% quarter-over-quarter to $2.81B.
Based on Central Trust Company's 13F filing for Q3 2021, filed 19 Oct 2021.